Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05568043 · ClinicalTrials.gov registry record · NA

The Reducing REVISITS Study: A Cluster RCT

A NA study of COPD and COPD Exacerbation Acute, sponsored by University of Chicago.

Recruiting
Registry status
NA
Development phase
24
Enrollment target
1
Study location

NCT05568043: Recruiting NA study of COPD and COPD Exacerbation Acute, sponsored by University of Chicago.

NCT05568043 is a NA study of COPD and COPD Exacerbation Acute that is actively recruiting participants, run by University of Chicago. The registered enrollment target is 24 participants, below the 2,418-participant average among 85 other COPD trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05568043, a NA study of COPD and COPD Exacerbation Acute, is actively recruiting participants, sponsored by University of Chicago.

RECRUITING
Registry status
NA
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

This type II hybrid effectiveness-implementation trial will concurrently study the comparative effectiveness of virtual vs. in-person COPD care transition programs implemented via virtual mentored implementation approaches with and without co-design methods. The investigators will enroll up to 24 randomized sites (with a goal minimum of 16 sites) to: * Deliver the COPD programs implemented via mentored support in collaboration with SHM Center for Quality Improvement. * Compare the effectiveness and penetration of virtual versus in-person COPD care transition programs implemented along with mentoring support with or without co-design. The investigators aim to determine which combined approach(es) is/are the most effective at implementing evidence-based COPD program interventions and decreasing COPD acute care revisits with the greatest overall impact and sustainability.

Primary Outcome

Composite of all emergency department visits and/or re-hospitalizations within 30-days post index hospitalization across all enrolled sites for COPD

Interventions

  • BEHAVIORAL COPD Transitions of Care Intervention Bundle: Virtual Interventions
  • BEHAVIORAL COPD Transitions of Care Intervention Bundle: In-Person Interventions

Study Locations (1)

Illinois

  • University of Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2022-02-15
Est. Completion 2026-03-31
Phase NA
University of Chicago

796 total trials

What NCT05568043 shows while recruiting

NCT05568043 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 2,418-participant average among 85 other COPD trials with a reported enrollment target (99% lower).

The record links to 2 conditions, with COPD appearing as the primary indexed condition, and to 2 interventions - of which COPD Transitions of Care Intervention Bundle: Virtual Interventions is the first listed.

NCT05568043 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT05568043 about?

NCT05568043 is a clinical study titled "The Reducing REVISITS Study: A Cluster RCT". This type II hybrid effectiveness-implementation trial will concurrently study the comparative effectiveness of virtual vs. in-person COPD care transition programs implemented via virtual mentored implementation approaches with and without co-design methods. The investigators will enroll up to 24 r...

What is the current status of trial NCT05568043?

This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2022-02-15. Estimated completion is 2026-03-31.

What conditions does trial NCT05568043 study?

This clinical trial studies the following conditions: COPD, COPD Exacerbation Acute.

What interventions are being tested in trial NCT05568043?

The interventions under investigation include: COPD Transitions of Care Intervention Bundle: Virtual Interventions (BEHAVIORAL), COPD Transitions of Care Intervention Bundle: In-Person Interventions (BEHAVIORAL).

Who is sponsoring clinical trial NCT05568043?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05568043 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for COPD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05568043's enrollment target sits among peer trials

24 73rd of 85 higher than 13 of 85 other COPD trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other COPD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02331979 · 24 participants · NA

    Improving Bladder Function in SCI by Neuromodulation

  • NCT03096197 · 24 participants · NA

    Exoskeleton and Spinal Cord Stimulation for SCI

  • NCT03223922 · 24 participants · NA

    Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

  • NCT03326921 · 24 participants · Phase 1

    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05568043, the US trial registry maintained by the National Library of Medicine. NCT05568043 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.